HIV Research & Development
Clinical research is an integral part of health care and one of the best ways to get new and improved treatments or access to new medications. The clinical trials and research opportunities available at the Partnership evaluate experimental drugs and treatment options for patients at all stages of HIV disease. Our clinical drug study coordinator guides patients through all stages of the research process and provides expert coordination of the health care of all research participants.
Benefits of enrolling in a clinical trial
- You may gain access to investigational new drugs to treat your HIV infection that are otherwise unavailable.
- If you are uninsured, you may be able to receive medication, medical exams, laboratory tests and information about your health for free.
- Your health will be monitored more closely.
- If you have tried most of the anti-HIV drugs that are already approved by the FDA, and your virus is now resistant to them, you may have the opportunity to be treated with newer drugs that are not yet on the market.
- Your participation may also help the FDA (Food and Drug Administration) decide whether the drugs being tested work in suppressing your HIV (lowering the amount of HIV in your blood), and if they are safe for you and other people who are infected with HIV.
Risks of participating in a clinical trial
- You might not be able to continue the medications that you are taking for other illnesses while you are in the study.
- The treatment might not work for you
- There may be side effects from the new drug
- You may have to see your doctor more often than you otherwise would
Researchers at the Partnership
Mariana Bernui, PhD
Assistant Professor, Clinical Research Manager
Carolyn Edwards, RN, MSN
Clinical Research Manager
Professor of Medicine; MD/PhD Program Director
Department: Medicine: Division of Infectious Diseases & HIV Medicine
Research Overview: Dr. El Haddad is an immunologist and cell biologist by training. His research sits at the interface of four disciplines: human immunology, systems biology, infectious disease pathogenesis and vaccinology. Dr. El Haddad’s research portfolio combines basic science and applied clinical research aiming at developing vaccine adjuvants, improving vaccine efficacy, developing immunotherapies and identify digital biomarkers in personalized medicine. His research also emphasizes examining immune responses in special populations, such the elderly, aiming at developing efficacious vaccines to improve their immune response and reduce the burdens of many infectious diseases in this population.
Associate Dean for Faculty; Associate Professor of Medicine; Associate Professor of Microbiology & Immunology
Department: Medicine: Division of Infectious Diseases & HIV Medicine; Microbiology & Immunology
Research Overview: Our laboratory carries out highly translational research in the area of vaccinology, immunology and infectious disease. The laboratory aims to develop next generation optimized DNA vaccine based strategies that target antigen-specific cellular and humoral immune responses to mucosal sites.
Theresa Linus, RN, BSN
Clinical Research Coordinator
Kim Malone, BS, NRCMA, NRCPT
The information on these pages is provided for general information only and should not be used for diagnosis or treatment, or as a substitute for consultation with a physician or health care professional. If you have specific questions or concerns about your health, you should consult your health care professional.
The images being used are for illustrative purposes only; any person depicted is a model.
Back to Top